Arcadia Biosciences Inc logo

Arcadia Biosciences Inc(RKDA)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$0.19
11/17/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for RKDA

11/17/2026: RKDA (1-star) is currently NOT-A-BUY. Pass it for now.

Arcadia Biosciences Inc is a micro-cap consumer wellness and beverage stock centered primarily around its Zola coconut water brand. The company's main operational strength lies in steady volume growth and solid gross margins for Zola following its pivot away from capital-intensive agricultural biotech. Its primary investment story rests on expanding distribution channels and launching new product formulations like espresso and slim cans. However, the company faces significant risks, including persistent net operating losses, a micro-cap valuation, intense competition from beverage giants, and execution hurdles. The stock may suit speculative or momentum-oriented investors willing to monitor cash burn rates and quarterly volume growth closely.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitWhile Zola shows pockets of volume growth, the company's micro-cap size and small revenue base limit traditional growth appeal.
Momentum investorStrong fit while signal remains positiveLow share price and small float can generate sharp short-term trading momentum during positive earnings or product announcements.
Value investorWeak fitPersistent net losses and negative cash flows make traditional value metrics unsupportive.
Dividend investorWeak fitThe company pays no dividends and reinvests all capital into basic operations.
Low-risk investorWeak fitMicro-cap stock volatility, thin liquidity, and ongoing operational losses present high risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighMicro-cap status and low trading float lead to sharp daily price swings.
Valuation riskMedium / highUnpredictable earnings and cash burn complicate fundamental valuation.
Competition risk (beverage brand competition)HighArcadia competes against dominant global beverage companies with massive distribution power.
Business qualityLowSmall revenue scale and ongoing unprofitability limit franchise strength.
Dividend incomeLow / noneNo dividends are paid to shareholders.
Execution riskHighManagement must successfully scale Zola distribution with limited financial resources.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.15M USD
Price to earnings Ratio -
1Y Target Price 12
Price to earnings Ratio -
1Y Target Price 12
Volume (30-day avg) 3.0M shares
Beta 0.59
52 Weeks Range 0.11 - 3.87
Updated Date 11/17/2026
52 Weeks Range 0.11 - 3.87
Updated Date 11/17/2026
Dividends yield (FY) -
Basic EPS (TTM) -4.55

Sector & Industry Intelligence

Sector

Consumer Defensive

Defensive
Sentiment
Correction Expected
Momentum
BUY Breadth Improving
BUY participation
95.8%
Active BUY / eligible
23 / 24
30-Day BUY Count Change
+14
Market state
Correction Expected

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Packaged Foods

BUY participation
100.0%
Active BUY / eligible
1 / 1
30-Day BUY Count Change
+1

Eligible universe: 1 stock.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
PRICE STABILITY

Extreme Price Shocks

The stock has experienced exceptionally large and disruptive price movements during the period.

Analysis of Past Performance

Type Stock
Historic Profit -37.49%
Avg. Invested days 30
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/17/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
RKDA receives a 2-star rating, reflecting soft or weak scores across the available pillars. The rating is constrained by weak unit economics, and weak price momentum.

Company Fundamentals

★★★★★
RKDA has moderate overall fundamentals (3 stars), with soft financial health, solid growth momentum, and moderate ownership. In FY2025 versus FY2024, strong earnings growth (+66.8%) is partially offset by weak cash generation (FCF margin -97.6%), slightly negative revenue growth (-3.7%), weak profitability (net margin -48.1%).

Financial Health Rating

★★★★★
RKDA's financial health is soft, with the relatively strongest area being solid liquidity, including working-capital and asset support (WC/assets 65.6%). Operating efficiency is soft (2 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is RKDA's strongest growth driver at +66.8% FY2025 versus FY2024 (strong, 5 stars). By comparison, free-cash-flow growth (+50.9%, strong) is also strong, while revenue growth (-3.7%, slightly negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 17.7% (soft) and 35.7% of outstanding shares are publicly tradable (moderate). Insider ownership of 15.87% supports management-shareholder alignment.

Top 5 Institutional Investors

HRT FINANCIAL LLC 3.67%
Citadel Advisors Llc 0.99%
Virtu Financial LLC 0.90%
Geode Capital Management, LLC 0.67%
XTX Topco Ltd 0.64%

Unit Economics (Per $1K Revenue)

★★★★★
RKDA generates approximately $362 of gross profit, $-2,057 of operating income, and $-976 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -0.34% (Tax Credit)

Quantitative Style Profile

★★★★★
RKDA has a relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Consumer Beverages (Zola)Wholesale and retail sales of Zola coconut water and related beverage formulations.This is the core engine generating nearly all of the company's active revenue.
Licensing and Residual AssetsRoyalties and payments tied to historical agricultural technology and asset sales.Provides occasional non-operating cash inflows but is no longer a primary growth driver.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-12
When -
Estimate -
Actual 0.29

Profitability

Profit Margin -234.53%
Operating Margin (TTM) -80.15%

Management Effectiveness

Return on Assets (TTM) -34.76%
Return on Equity (TTM) -430.93%

Valuation

Trailing PE -
Forward PE 36.63
Enterprise Value -3.96M
Price to Sales(TTM) 0.24
Enterprise Value -3.96M
Price to Sales(TTM) 0.24
Enterprise Value to Revenue 0.06
Enterprise Value to EBITDA 0.62
Shares Outstanding 6.07M
Shares Floating 2.17M
Shares Outstanding 6.07M
Shares Floating 2.17M
Percent Insiders 15.87
Percent Institutions 17.69

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.